Femme et Homme
- | Pays :
- Canada
- Ireland
- Switzerland
- Les 12 autres...
- | Organes : -
- | Spécialités : -
Extrait
This Open-label extension study in patients with Idiopathic Pulmonary Fibrosis who completed protocol AC-052-321 / BUILD 3 (NCT00391443) will asses the long term safety and tolerability of bosentan in patients with idiopathic pulmonary fibrosis (IPF).
Critère d'inclusion
- Idiopathic pulmonary fibrosis